Please Wait
Applying Filters...
menu
    • menu
    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    Topscience Biotech specializes in R&D, production, and sales of Sodium Hyaluronate, focusing on Medical and Pharmaceutical Grade HA.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Menu

    Amprenavir

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Vertex Announces Program Updates for Type 1 Diabetes Portfolio
    Vertex Announces Program Updates for Type 1 Diabetes Portfolio

    28 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250328622122/en/Vertex-Announces-Program-Updates-for-Type-1-Diabetes-Portfolio

    BUSINESSWIRE
    28 Mar 2025
    Share Share
    Vertex to Participate in Upcoming September Investor Conferences
    Vertex to Participate in Upcoming September Investor Conferences

    22 Aug 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240822736102/en

    BUSINESSWIRE
    22 Aug 2024
    Share Share
    Vertex Reports Second Quarter 2024 Financial Results
    Vertex Reports Second Quarter 2024 Financial Results

    01 Aug 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240801201006/en

    BUSINESSWIRE
    01 Aug 2024
    Share Share
    Vertex: TRIKAFTA® Benefit Data At Cystic Fibrosis Conference
    Vertex: TRIKAFTA® Benefit Data At Cystic Fibrosis Conference

    07 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240606593406/en

    BUSINESSWIRE
    07 Jun 2024
    Share Share
    Vertex touts Casgevy sickle cell launch as bluebird makes progress Lyfgenia
    Vertex touts Casgevy sickle cell launch as bluebird makes progress Lyfgenia

    06 May 2024

    // ENDPTS

    https://endpts.com/vertex-touts-casgevy-sickle-cell-launch-as-bluebird-makes-progress-with-rival-lyfgenia/

    ENDPTS
    06 May 2024
    Share Share
    Vertex Advances Inaxaplin into Ph 3 for the Treatment of APOL1-Mediated KD
    Vertex Advances Inaxaplin into Ph 3 for the Treatment of APOL1-Mediated KD

    01 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240401112879/en

    BUSINESSWIRE
    01 Apr 2024
    Share Share